logo
logo
Sign in

European Veterinary Antibiotics Market: Trends, Challenges, and Opportunities

avatar
Steve Anderson
European Veterinary Antibiotics Market: Trends, Challenges, and Opportunities

The Europe veterinary antibiotics market size is expected to reach USD 1.31 billion by 2030, registering a CAGR of 3.59% over the forecast period, according to a new report by Grand View Research, Inc. The rising focus on animal-only antibiotics and ionophores, the launch of new products, and the increasing use of veterinary antibiotics are some of the major factors augmenting the industry's growth. In addition, the rising prevalence and incidence of livestock diseases and concerns regarding zoonoses are further propelling the industry's growth. The COVID-19 pandemic has affected the veterinary antibiotic business operations of key players and resulted in declined financial performance during the initial time.

Europe Veterinary Antibiotics Market Report Highlights

  • The cattle animal type segment accounted for the largest revenue share in 2021 owing to the easy availability of cattle antibiotics and increased consumption of beef & dairy products
  • By drug class, the penicillin segment held the largest revenue share in 2021. Penicillinis one of the most commonly sold antibiotic drug classes in Europe for veterinary application
  • According to the EMA, the overall sales of veterinary penicillin accounted for 31.1% in 2020
  • The oral solution segment led the market in 2021 owing to the easy & convenient usage of these dosage forms. These solutions are preferably dispensed in the drinking water
  • The U.K. accounted for the largest revenue share in 2021 and Poland is expected to grow at the fastest CAGR from 2022 to 2030
  • Key factors contributing to the notable share of the U.K. include the easy availability of veterinary antibiotics and an increase in pet ownership & pet insurance rates
  • The industry is fairly competitive owing to the presence of major players. Various strategic initiatives implemented by companies are greatly contributing to the growth of the industry

Gain deeper insights on the market and receive your free copy with TOC now @: Europe Veterinary Antibiotics Market Report

The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, with the easing of restrictions, manufacturers were able to supply antibiotics to meet the necessary veterinary requirements. Few major players have reported significant growth in antibiotic sales despite the pandemic. For instance, Virbac’s bovine antibiotic sales grew from USD 66.98 million in 2020 to USD 79.30 million in 2021. The global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Despite the regulatory changes implemented by the European Medicines Agency (EMA) for restriction and ban on routine antibiotic use, the overall sales of veterinary antimicrobial active ingredients have observed significant growth in the past few years.

For instance, according to the EMA, overall veterinary antimicrobial active substance sales grew from 5,282 tonnes in 2019 to 5,562 tonnes in 2020. Furthermore, major players, such as Elanco, have shifted their focus to animal-only antibiotics, as a measure to address antibiotic resistance while also protecting animal health. Key players are implementing various strategic initiatives, such as mergers, partnerships, acquisitions, collaborations, and new product launches, to maintain their competitive edge. For instance, in December 2021, Virbac, in collaboration with Pharmgate, launched Tulissin, an antibiotic solution for swine and cattle with respiratory pathologies. These activities are expected to intensify the competition between major antibiotic manufacturers in the coming years.

For More Details or Sample Copy please visit link @: https://www.grandviewresearch.com/industry-analysis/europe-veterinary-antibiotics-market-report/request/rs1

List of Key Players of Europe Veterinary Antibiotics Market

  • Merck & Co., Inc.
  • Ceva
  • Zoetis
  • Boehringer Ingelheim GmbH
  • Elanco
  • Vetoquinol S.A.
  • Virbac
  • Calier
  • Bimeda, Inc.
  • Prodivet pharmaceuticals SA/NV

Research Methodology

We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.

For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/checkout/select-license/europe-veterinary-antibiotics-market-report

Segmented the Europe veterinary antibiotics market based on animal type, drug class, dosage form, and region:

Table of Contents

Chapter 1 Methodology And Scope

          1.1 Market Segmentation And Scope

            1.1.1 Segment Scope

            1.1.2 Country Scope

            1.1.3 Estimates And Forecast Timeline

          1.2 Research Methodology

          1.3 Information Procurement

            1.3.1 Purchased Database:

            1.3.2 Gvr’s Internal Database

            1.3.3 Secondary Sources

            1.3.4 Primary Research

            1.3.5 Details Of Primary Research

          1.4 Information/Data Analysis

            1.4.1 Data Analysis Models

          1.5 Market Formulation & Validation

          1.6 Model Details

            1.6.1 Commodity Flow Analysis

          1.7 List Of Secondary Sources

Chapter 2 Executive Summary

          2.1 Europe Veterinary Antibiotics Market Outlook

            2.1.1 Segment Outlook

            2.1.2 Country Outlook

            2.1.3 Competitive Outlook

          2.2 Europe Veterinary Antibiotics Market Snapshot, 2021

          2.3 Overall Estimated Sales Of Antimicrobial Vmps (Active Substance) In Tonnes By Country, In 2019/2020

          2.4 Estimated Sales Of Antimicrobial Active Substances By Antimicrobial Class, 2019/2020

Chapter 3 Europe Veterinary Antibiotics Market Variables, Trends & Scope

          3.1 Market Lineage Outlook

            3.1.1 Parent Market Analysis

            3.1.2 Ancillary Market Analysis

          3.2 Penetration And Growth Prospect Mapping

          3.3 Europe Veterinary Antibiotics Market Dynamics

            3.3.1 Market Driver Analysis

              3.3.1.1 Rising Focus On Animal-Only Antibiotics And Ionophores

              3.3.1.2 Growing Initiatives By Key Companies Or Launch Of New Products

              3.3.1.3 Prudent And Responsible Use Of Antibiotics

            3.3.2 Market Restraint Analysis

              3.3.2.1 Stringent Regulations

              3.3.2.2 Decline In Use Of Antibiotics

              3.3.2.3 Active Research On Antibiotic Alternatives

            3.3.3 Market Opportunity Analysis

            3.3.4 Market Challenge Analysis

          3.4 Industry Analysis

            3.4.1 Porter’s Analysis

              3.4.1.1 Supplier Power

              3.4.1.2 Buyer Power

              3.4.1.3 Threat Of Substitutes

              3.4.1.4 Threat Of New Entrants

              3.4.1.5 Competitive Rivalry

            3.4.2 Pestel Analysis

              3.4.2.1 Political & Legal Landscape

              3.4.2.2 Economic & Social Landscape

              3.4.2.3 Environmental Landscape

              3.4.2.4 Technology Landscape

          3.5 Regulatory Framework

            3.5.1 Dossier Requirements

          3.6 Patent-Off Dates Analysis For Major Veterinary Antibiotics

          3.7 Product Pipeline Analysis

          3.8 COVID-19 Impact Analysis

            3.8.1 Current And Future Impact Analysis

            3.8.2 Impact On Market Players

Chapter 4 Animal Type Estimates & Trend Analysis, 2017 - 2030 (USD Million)

          4.1 Animal Type Movement Analysis, 2017 - 2030 (USD Million)

          4.2 Europe Veterinary Antibiotics Market Share Analysis, 2021 & 2030

          4.3 Pigs

            4.3.1 Pigs Market Estimates And Forecasts, 2017 - 2030 (USD Million)

          4.4 Cattle

            4.4.1 Cattle Market Estimates And Forecasts, 2017 - 2030 (USD Million)

          4.5 Sheep & Goats

            4.5.1 Sheep & Goats Market Estimates And Forecasts, 2017 - 2030 (USD Million)

          4.6 Poultry

            4.6.1 Poultry Market Estimates And Forecasts, 2017 - 2030 (USD Million)

          4.7 Others

            4.7.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

Chapter 5 Drug Class Estimates & Trend Analysis, 2017 - 2030 (USD Million)

          5.1 Drug Class Movement Analysis, 2017 - 2030 (USD Million)

          5.2 Europe Veterinary Antibiotics Market Share Analysis, 2021 & 2030

            5.2.1 Tetracyclines

              5.2.1.1 Tetracyclines Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.2 Penicillins

              5.2.2.1 Penicillins Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.3 Sulfonamides

              5.2.3.1 Sulfonamides Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.4 Macrolides

              5.2.4.1 Macrolides Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.5 Trimethoprim

              5.2.5.1 Trimethoprim Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.6 Lincosamides

              5.2.6.1 Lincosamides Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.7 Polymyxins

              5.2.7.1 Polymyxins Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.8 Aminoglycosides

              5.2.8.1 Aminoglycosides Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.9 Fluoroquinolones

              5.2.9.1 Fluoroquinolones Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.10 Pleuromutilins

              5.2.10.1 Pleuromutilins Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            5.2.11 Others

              5.2.11.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)

Chapter 6 Dosage Form Estimates & Trend Analysis, 2017 - 2030 (USD Million)

          6.1 Dosage Form Movement Analysis, 2017 - 2030 (USD Million)

          6.2 Europe Veterinary Antibiotics Market Share Analysis, 2021 & 2030

            6.2.1 Oral Powder

              6.2.1.1 Oral Powder Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            6.2.2 Oral Solutions

              6.2.2.1 Oral Solutions Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            6.2.3 Injections

              6.2.3.1 Injection Market Estimates And Forecasts, 2017 - 2030 (USD Million)

            6.2.4 Others

              6.2.4.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)

collect
0
avatar
Steve Anderson
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more